This is a working overview of actin binding, written for readers who want more than a one-paragraph summary but less than a textbook.
This page was last updated on 2025-07-30 and is reviewed periodically as new material appears.
Purity is normally assessed by reversed-phase HPLC, with the main peak reported as a percentage of total peak area, while identity is confirmed by mass spectrometry. Electrospray and MALDI-TOF instruments are both used, and the observed mass is compared with the value calculated from the stated sequence. Ion-exchange or size-exclusion methods appear where aggregation or charge variants are of interest. Water content, counter-ion content and residual trifluoroacetate from purification are separate variables that can shift the measured mass and should be weighed when reading a certificate of analysis.
Research peptides are typically supplied as a white to off-white lyophilised powder in a sealed vial. The dry solid is more stable than a solution and is normally kept refrigerated or frozen until use. Dissolution is usually done in water, phosphate-buffered saline or a similar aqueous medium, depending on the assay. Because the material is hygroscopic and easily contaminated, opening vials in a low-humidity environment and recording the lot number before use are standard laboratory practices.
Interest in the compound comes largely from studies of the parent protein, which participates in actin sequestration, cell migration and tissue repair processes. Whether a short fragment reproduces those activities is a separate question that remains open in the published record. Many summaries describe mechanisms by analogy to thymosin beta-4 rather than from direct measurements on the fragment. Claims about activity should be treated as provisional unless a cited study specifies the exact peptide, its purity and the assay used.
TB-500 is a laboratory label applied to a short synthetic peptide that is widely described as a fragment of thymosin beta-4, an actin-binding protein present in most mammalian cells. Suppliers and review articles usually present TB-500 as the N-terminal region of that protein, but the exact sequence attached to the name is not consistent across sources. Some product descriptions list a seven-residue chain; others use the label loosely for the parent protein itself. Because of that variation, any technical discussion of TB-500 needs to state which sequence is meant.
| Property | Value | Notes |
|---|---|---|
| Typical form | Lyophilised powder | Reconstituted before use |
| Storage temperature, dry | -20 °C or below | Desiccated, protected from light |
| Purity determination | Reversed-phase HPLC | Reported as percentage of total peak area |
| Identity confirmation | Mass spectrometry | ESI or MALDI-TOF versus calculated mass |
| Common synonyms | Tβ4 fragment; thymosin beta-4 fragment | Naming varies between suppliers |
Identity and purity are assessed with a small set of standard techniques. Reverse-phase high-performance liquid chromatography gives a purity estimate from peak area, usually recorded at 214 or 220 nanometers, where the peptide bond absorbs. Mass spectrometry confirms the expected molecular mass and can reveal truncated or oxidized species. Amino acid analysis or tandem mass spectrometry sequencing can verify the sequence itself. Additional quality attributes include water content, residual trifluoroacetic acid carried over from purification, and endotoxin where the material is intended for biological work.
The compound is most often distributed as a lyophilized powder, appearing white to off-white and forming a loose cake or fluffy solid. It is hygroscopic to some degree, so brief exposure to humid air can add water weight and complicate weighing. The peptide dissolves readily in water and in neutral aqueous buffers, and aqueous solubility is generally described as high, well above the concentrations used in typical assays. Some polar organic solvents are also usable, which matters when a concentrated stock is prepared before dilution into buffer.
Storage recommendations center on keeping the dry powder cold, dry, and dark. A freezer at -20 degrees Celsius or below is conventional, and desiccant is often included to limit moisture uptake. Once dissolved, the peptide is less stable, and solutions are typically kept frozen and thawed only once. Repeated freeze-thaw cycles are a common source of losses because they promote aggregation and adsorption to container surfaces. Working aliquots are therefore prepared in advance, and glass or low-binding plastic is usually preferred over ordinary laboratory plastic.
Discussion of TB-500 appears in several distinct literatures that rarely cite one another. Peer-reviewed studies usually describe in vitro assays or small animal experiments and are cautious about extrapolation. Veterinary and sports communities circulate anecdotal reports with limited methodological detail. Commercial listings add a third layer, often using the name interchangeably with thymosin beta-4 even though the two molecules differ in size and sequence. Regulatory status varies by country, and the compound is not a licensed medicine in most jurisdictions, so readers comparing sources should check which molecule and which purity each source actually describes.
TB-500 is a synthetic seven-residue peptide whose sequence, LKKTETQ, matches the N-terminal actin-binding region of thymosin beta-4. It is usually supplied in an N-terminally acetylated form, a modification that blocks the free amino terminus and can influence behavior in solution. In the research literature the same sequence appears under several names, including thymosin beta-4 fragment and shortened thymosin beta-4. Because it is a short peptide rather than the full 43-residue parent protein, its measured properties differ from those reported for thymosin beta-4 as a whole, and the two are not interchangeable in experimental design.
Thymosin beta-4 itself is a small, widely expressed protein that sequesters monomeric actin and participates in cell migration, angiogenesis, and tissue repair. Researchers have examined the shortened fragment as a possible mimic of some of these activities, reasoning that the actin-binding motif lies within the first few residues. Binding to monomeric actin has been observed in cell-free systems. Whether the fragment reproduces the broader effects of the full protein in living tissue remains an open question, and findings from animal models are frequently cited without a clear bridge to human physiology.
Animal work has examined the peptide in models of cardiac injury, skin wounding, and corneal repair, with reported outcomes covering cell migration, inflammatory cell influx, and tissue remodeling. Several of those experiments used the full-length protein or longer fragments instead of the seven-residue sequence, which makes direct comparison between reports difficult. Results are generally described as tissue-dependent, and effect sizes vary considerably across laboratories. Independent replication is uneven, so the overall picture is incomplete rather than settled.
Controlled human trials of the short fragment are scarce. Much of what appears in review articles is extrapolated from animal models or from studies of the parent protein, and literature searches return a larger body of cardiac and ophthalmic work on thymosin beta-4 than on the abbreviated peptide. Regulatory treatment differs by jurisdiction, and in several countries the material is handled as a research chemical rather than an approved therapeutic. Statements about human benefit should be read as provisional.
Biological interest in this peptide centers on its relationship to actin dynamics. Thymosin beta-4 binds monomeric actin through an LKKTET motif, and a short sequence carrying that motif can compete with other actin-binding proteins in cell-free preparations. Investigators propose that such competition shifts the balance between filament assembly and disassembly, which in turn affects how readily a cell extends protrusions and migrates. Most of the supporting observations come from cultured cells and purified protein systems rather than from intact organisms.
Material sold under this label typically arrives as a freeze-dried powder in a sealed vial with a certificate of analysis. Such certificates usually report reversed-phase chromatography purity plus a mass confirmation, and stated purities commonly sit between 95 and 99 percent. Counter-ion identity, residual trifluoroacetate, water content, and peptide net weight are separate specifications that a certificate may or may not include. A purity figure alone does not establish sequence identity, so independent mass verification remains the practical check.
The designation TB-500 circulates in laboratory and catalog contexts without a single agreed definition. Most product listings apply it to an N-terminally acetylated seven-residue fragment of thymosin beta-4, while other listings attach the same label to the full 43-residue protein. Because the term is commercial rather than systematic, two entries bearing identical names may describe different molecules. Any documentation should therefore state which sequence a given sample is claimed to contain.
In 2001, a US-led military coalition invaded Afghanistan and toppled the ruling Taliban as part of the war on terror response to 9/11. For generations, Afghanistan had been producing opium; the Taliban, in power since 1996, banned opium in 2000, reducing domestic production by 90% within a year, cutting the world opium supply by an estimated 65%. With the invasion, poppy cultivation and opium manufacture resumed, and the war on drugs became an element of the US presence. Initially, "everyone did their own thing, not thinking how it fit in with the larger effort. State was trying to eradicate, USAID was marginally trying to do livelihoods, and DEA was going after bad guys", a senior Department of Defense official stated in a later report. In 2004, opium production dramatically increased and eradication became the focus. The DEA operating budget in Afghanistan grew from $3.7 million in 2004 to $40.6 million in 2008. In 2009, eradication was halted – a senior US official called it "the least effective program ever" – in favor of an "alternative livelihoods" approach that encouraged farmers to grow other crops. In 2017, eradication once again became the main initiative; the US military launched an aerial campaign involving B-52 bombers and F-22 fighters striking a network of drug labs that turned out to be mostly empty compounds, though there were significant civilian casualties. Undermining US efforts, the prohibitionist policies encouraged a flourishing opium black market, which in turn incentivized widespread, systemic corruption in the Afghan government.
== See also == Renin-angiotensin system: When the blood flow through the juxtaglomerular apparatus decreases, blood pressure is considered low, and the adrenal cortex secretes aldosterone to increase sodium reabsorption in the collecting duct, thereby increasing blood pressure. Bainbridge reflex: In response to stretching of the right atrium wall, heart rate increases, lowering venous blood pressure. Baroreflex: When the stretch receptors in the aortic arch and carotid sinus increase, the blood pressure is considered to be elevated and the heart rate decreases to lower blood pressure. Antidiuretic hormone: The hypothalamus detects the extracellular fluid hyperosmolality and the posterior pituitary gland secretes antidiuretic hormone to increase water reabsorption in the collecting duct.
== Further reading == Kelly, Evelyn B. (2013-01-07). Encyclopedia of Human Genetics and Disease [2 volumes]. ABC-CLIO. ISBN 9780313387142. Carakushansky, Gerson; Ribeiro, Marcia Gonçalves; Kahn, Evelyn (2011). "Moderately progressive Ullrich congenital muscular dystrophy". Jornal de Pediatria. 88 (1): 93–96. doi:10.2223/JPED.2112. ISSN 0021-7557. PMID 22016142. "National Guideline Clearinghouse | Evidence-based guideline summary: evaluation, diagnosis, and management of congenital muscular dystrophy: report of the Guideline Development Subcommittee of the American Academy of Neurology and the Practice Issues Review Panel of the American Association of Neuromuscular and Electrodiagnostic Medicine". www.guideline.gov. Archived from the original on 2016-04-08. Retrieved 2016-05-12. Hicks, D.; Lampe, A. K.; Laval, S. H.; Allamand, V.; Jimenez-Mallebrera, C.; Walter, M. C.; Muntoni, F.; Quijano-Roy, S.; Richard, P.; Straub, V.; Lochmuller, H.; Bushby, K. M. D. (16 November 2008). "Cyclosporine A treatment for Ullrich congenital muscular dystrophy: a cellular study of mitochondrial dysfunction and its rescue" (PDF). Brain. 132 (1): 147–155. doi:10.1093/brain/awn289. PMID 19015158. Retrieved 12 May 2016.
=== Pharmacogenomics === Genetic variations in cytochrome P450 enzymes can influence exposure to vortioxetine. CYP2D6 extensive metabolizers have approximately 2-fold higher clearance of vortioxetine than CYP2D6 poor metabolizers. The estimated clearance rates were 52.9, 34.1, 26.6, and 18.1 L/h for CYP2D6 ultra-rapid metabolizers, extensive metabolizers, intermediate metabolizers, and poor metabolizers. Area-under-the-curve levels of vortioxetine were 35.5% lower in CYP2D6 ultra-rapid metabolizers than in extensive metabolizers, though with significant overlap due to interindividual variability. Dosage adjustment for CYP2D6 ultra-rapid metabolizers is considered to not be necessary. Vortioxetine exposure in CYP2D6 poor metabolizers is expected to be approximately twice as high as in extensive metabolizers. Depending on the individual response, dosage adjustment may be considered for CYP2D6 poor metabolizers, with a maximum recommended dosage of 10 mg/day for known such individuals. In addition to CYP2D6, CYP2C19 extensive metabolizers have 1.4-fold higher clearance of vortioxetine than poor metabolizers. However, this is not considered to be clinically important and dose adjustment is not considered to be necessary based on CYP2C19 status.
Succimer aci or dimercaptosuccinic acid is the organosulfur compound with the formula (HSCH)2(CO2H)2. It is a dicarboxylic acid containing a two thiol functional groups. It is a white solid. Like many dithiols, it is a chelating agent, forming metal thiolate complexes.
Sources: en.wikipedia.org
1984: Ong Hwee Kuan, Ong Chin Hock and Yeo Ching Boon were hanged on 24 February 1984 for the robbery, kidnapping and murder of a policeman, Lee Kim Lai, on 25 April 1978. The trio were also responsible for the murder of a taxi driver Chew Theng Hin on the same night Lee was killed. 1986: Sim Min Teck, one of the three perpetrators of the 1980 Jurong fishing port murders, which he committed when he was 18. He was sentenced to death for murder in March 1985 and lost his appeal in July 1986, before he was hanged. 1988: Adrian Lim, Tan Mui Choo, and Hoe Kah Hong, the three perpetrators of the 1981 Toa Payoh ritual murders, were hanged on 25 November 1988. 1988: Sek Kim Wah, a Singaporean military conscript and serial killer who committed the 1983 Andrew Road triple murders and another double murder near Seletar Road, was hanged on 9 December 1988. As of 2024, Sek Kim Wah remains as Singapore's first and only serial killer to date, with 5 victims. 1990: Michael Tan Teow and Lim Beng Hai, the two unemployed Singaporeans and drug abusers who killed a housewife and two children to steal their money to buy drugs. Both were eventually charged with murder, convicted and sentenced to hang. Before his execution however, Tan committed suicide in May 1990, therefore, only Lim was put to death on 5 October 1990. 1992: Hensley Anthony Neville, a Eurasian Singaporean found guilty of the 1984 rape and murder of 19-year-old Lim Hwee Huang. He fled to Malaysia after killing Lim, but was caught in March 1987 and hanged on 28 August 1992 after a six-day trial hearing.
Because prophase and prometaphase chromosomes are more extended than metaphase chromosomes, the number of bands observable for all chromosomes (bands per haploid set, bph; "band level") increases from about 300 to 450 to as many as 800. This allows the detection of less obvious abnormalities usually not seen with conventional banding.
=== Return to Biotin receptor isolation === Hofmann came full circle to his early work on biotin when he attached this vitamin to insulin. He spent a sabbatical leave in Aachen in Helmut Zahn's laboratory to learn techniques for modifying insulin). Using this information, he was able to chemically attach biotin to one of the three Lys residues of the insulin chains, thus producing an insulin that would bind to columns of avidin-Sepharose. The biotinyl-insulin receptor complex could then be displaced by biotin. With this tool, Hofmann and his coworkers successfully isolated a fully active insulin receptor. His final work was directed toward isolation of the ACTH receptor using the same approach used on the insulin receptor but by this time his health was in decline.
== Structure == Lumican is a proteoglycan Class II member of the small leucine-rich proteoglycan (SLRP) family that includes decorin, biglycan, fibromodulin, keratocan, epiphycan, and osteoglycin. Like the other SLRPs, lumican has a molecular weight of about 40 kilodaltons and has four major intramolecular domains:
This new recommendation provides a five-week window For valid culture results that include births that occur up to a gestational age of at least 41 weeks. The culture-based screening approach is followed in most developed countries such as the United States, France, Spain, Belgium, Canada, Argentina, and Australia. . The risk-based strategy is followed in the United Kingdom, and the Netherlands.
Sources: en.wikipedia.org
==== Clean vehicle and clean energy home improvement tax credits eliminated ==== The tax credit for buying a new qualified electric vehicle or fuel cell electric vehicle is no longer available for purchases made after September 30, 2025. The tax credit for buying a used qualified electric vehicle or fuel cell vehicle from a licensed dealer is no longer available for purchases made after September 30, 2025. The tax credit for installing property to either recharge electric vehicles or to store or dispense clean-burning fuel will no longer be available after June 30, 2026. The tax credit for making qualified energy-efficient improvements to one's home will no longer be available for improvements put into service after December 31, 2025. The tax credit for installing solar electric panels, solar water heaters, wind turbines, geothermal heat pumps, fuel cells, or battery storage technology in one's home will no longer be available for improvements made after December 31, 2025.
In a 2024 survey by marketing research firm Ipsos, Asia–Pacific countries were significantly more optimistic than Western societies about generative AI and show higher adoption rates. Despite expressing concerns about privacy and the pace of change, 68% of Asia-Pacific respondents believed that AI was having a positive impact on the world, compared to 57% globally. According to a survey by SAS and Coleman Parkes Research, as of 2023, 83% of Chinese respondents were using the technology, exceeding both the global average of 54% and the U.S. rate of 65%. A UN report indicated that Chinese entities filed over 38,000 generative AI patents from 2014 to 2023, more than any other country. A 2024 survey by the Just So Soul social media app reported that 18% of respondents born after 2000 used generative AI "almost every day", and that over 60% of respondents like or love AI-generated content (AIGC), while less than 3% dislike or hate it. By mid-2025, companies were increasingly abandoning generative AI pilot projects as they had difficulties with integration, data quality and unmet returns, leading analysts at Gartner and The Economist to characterize the period as entering the Gartner hype cycle's "trough of disillusionment" phase. In an October 2025 survey by the Federal Reserve, one in four U.S. workers reported using generative AI at work during the previous month.
"Controversy surrounds both the drug study itself and the FDA approval," wrote NEJM editor-at-large Richard P. Wenzel, MD in 2002. The FDA approved the drug despite the advisory committee's split vote (10 to 10) due to concerns about the validity of the claimed efficacy and safety findings on the basis of a single trial. Eli Lilly spokeswoman Judy Kay Moore insisted that the company did not mastermind the ethics task force or steer the guideline-writing process. It was only a coincidence, Moore says, that the ethics task force and the Surviving Sepsis Campaign used the same P.R. firm, Belsito and Company.
The P-type calcium channel is a type of voltage-dependent calcium channel. Similar to many other high-voltage-gated calcium channels, the α1 subunit determines most of the channel's properties. The 'P' signifies cerebellar Purkinje cells, referring to the channel's initial site of discovery. P-type calcium channels play a similar role to the N-type calcium channel in neurotransmitter release at the presynaptic terminal and in neuronal integration in many neuronal types.
(Sponsored by The Association of Schools of Public Health (ASPH). Eaton DL & Cui J. (2023) "Biotransformation of Xenobiotics ", in Patty's Industrial Hygiene and Toxicology, 7th Edition, Ed. D. Paustenbach, J. Klaunig, L. Levy & H. Greim, Wiley Press. e91320 Eaton, DL, *Vandivort, TC & Gallagher, EP. (2025). Introduction to the Principles of Toxicology, In: Comprehensive Toxicology, C. McQueen, Editor, Elsevier Sciences, Vol. 1, General Principles, 4 th, Edition, Chap. 1, 2025. Eaton, D. L., Goldstein, B. D. & Henifin, M. S. (2025). Reference Guide on Toxicology. In Reference Manual on Scientific Evidence (4th ed., pp. 1027-1104–686). National Academies Press / Federal Judicial Center.
Sources: en.wikipedia.org
Sealed, desiccated and protected from light, at -20 °C or lower for long-term storage. Short-term storage at refrigerator temperature is common in working laboratories.
Synthesis routes, purification steps and the analytical method used all affect the reported figure. A purity number is only comparable when the chromatographic conditions and detection wavelength are stated.
It reports what the supplier measured on a sample, which is useful but not absolute. Independent mass confirmation on the received lot is the more reliable check.
No. TB-500 is a trade-style label used for a synthetic peptide described as a fragment of thymosin beta-4, while thymosin beta-4 is the full 43-residue protein. The two differ in size and are not interchangeable terms in analytical work.